For the latest COVID-19 Travel restrictions and recommendations please click here

SMi presents the Inaugural Transdermal and Microneedle Drug Delivery Conference

Transdermal and Microneedle Drug Delivery Post-Conference Workshops
26th January, 2022 | London

SMi is proud to present the Transdermal and Microneedle Drug Delivery Post-Conference workshop, taking place on the 26th January 2022, in London. Transdermal and Microneedle Drug Delivery Conference will explore real world applications of microneedles in drug delivery and strategies for device design while engaging in the latest innovations in device design and formulation with case studies from thought leaders.

DRIVe, a division within the Biomedical Advanced Research and Development Authority (BARDA), present the new technology behind their ‘beyond the needle’ programme. With an introduction to the programme, conversations about the challenges and the ability to ask questions about this new area of technology, this interactive workshop will have discussions about the manufacturing, regulations and the costs associated with moving away from the needle and syringe method of delivery. Join us to discover more about needless delivery and the potential impact this can have across the world.

  • Discover the potential to move to needless administration with conversations on manufacturing and costs.
  • Understand and evaluate the current market with relevant case studies.
  • Interact with industry professionals with Q&A sessions.
  • Speak with BARDA about moving towards the needless future with an opportunity to obtain funding.
  • Drug-Delivery Device Developers
  • Microneedle Device Developers
  • Transdermal Delivery Developers
  • Microarray Patch Developers
  • Medical Device Engineers
  • Primary Packaging Material Designers
  • Secondary Packagers
  • Smart Device Developers
  • Training Device Developers
  • Device-Safety Solution Providers
  • Drug Developers
  • Transdermal Drug Product Developers

Previous attendees include:

AbbVie; Alnylam Pharmaceuticals; Amgen; Aptar Pharma; AstraZeneca; Bayer AG; BD Medical; Bd Medical-Pharmaceutical Systems; Becton dickinson; Becton Dickinson (BD); Bespak Europe Ltd; Boehringer Ingelheim; Boehringer Ingelheim GmbH; Boehringer Ingelheim Pharma GmbH & Co. KG; BSI; BSI Group; Cardiff University; CSL Behring AG; Eveon; F. Hoffman-La Roche Ltd.; F. Hoffmann-La Roche Ltd.; Ferring Pharmaceuiticals Pvt. Ltd.; FERRING PHARMACEUTICALS PVT LTD; Gerresheimer Buende GmbH; GlaxoSmithKline; GlaxoSmithKline (GSK); GSK; Haughton Design Ltd; Institute BCN Esthetics, S.L.; Ipsen; Ipsen Group; IPSEN Pharmsciences; Janssen; Janssen Pharmaceutica NV; Janssen Pharmaceutical Companies of Johnson and Johnson; Janssen Research and Development, LLC; Johnson & Johnson (Janssen Pharmaceutical); kaleo, Inc.; LEO Pharma A/S; Medicines & Healthcare Products Regulatory Agency (MHRA); MedinCell; Merck; MHRA; Minapharm Pharmaceuticals; Nemera; Nipro PharmaPackaging Germany; Novartis; Novartis – Global Drug Development; Novartis Pharma AG; Novartis Pharmaceuticals; Novo Nordisk; Novo Nordisk A/S; Novo Nordisk Pharma; Owen Mumford; PCI Pharma Services; Pfizer; Pfizer Inc.; Pfizer Ltd UK; Pfizer UK Limited; Pfizer, INC.; Regeneron Pharmaceuticals, Inc.; Rhein Minapharm; Roche; RSK-Solutions/ RSK Life Science Media; Sanofi; Sanofi SWI; TERUMO coeporation; Teva Ltd; Teva Pharmaceuticals; Teva UK; Teva, Combination Products; TUV SUD Japan Ltd.; UCB; UCB Pharma; W.L. Gore & Associates, Inc.; West Pharmaceutical Services; Zeon Corporation; Zeon Europe GmbH; Zeon Specialty Materials

Workshop programme

8:30 Registration & Coffee

9:00 Opening Remarks and Introductions

Kerry DeMarco

Kerry DeMarco, DRIVe Start Program Innovation & Alliance Lead, Biomedical Advanced Research & Development Authority (BARDA)
View Bio

9:10 A review and discussion of the ‘Beyond the Needle’ programme

Kerry DeMarco

Kerry DeMarco, DRIVe Start Program Innovation & Alliance Lead, Biomedical Advanced Research & Development Authority (BARDA)
View Bio

  • The vision and need for change.
  • The challenges to overcome – talking logistics.
  • 9:50 Current areas of application and focus

    Kerry DeMarco

    Kerry DeMarco, DRIVe Start Program Innovation & Alliance Lead, Biomedical Advanced Research & Development Authority (BARDA)
    View Bio

  • A look into real world examples of moving away from needle-based administration.
  • Case studies
  • 10:30 Morning Coffee

    11:00 How to go needle free, an interactive session.

    Kerry DeMarco

    Kerry DeMarco, DRIVe Start Program Innovation & Alliance Lead, Biomedical Advanced Research & Development Authority (BARDA)
    View Bio

  • Discussion on how to move current products away from needle-based administration, the costs vs the impact.
  • Understanding the barriers to face, including the skin.
  • Alternative methods of manufacturing – how BARDA can help.
  • 12:00 A future outlook and open discussion.

    Kerry DeMarco

    Kerry DeMarco, DRIVe Start Program Innovation & Alliance Lead, Biomedical Advanced Research & Development Authority (BARDA)
    View Bio

  • An opportunity to ask questions about moving ‘beyond the needle’.
  • The overall importance of needle free administration and the shortfalls of the need to inject medications around the world.
  • How to collaborate with BARDA moving forward and learn about their funding opportunities
  • 12:30 Closing Remarks

    Kerry DeMarco

    Kerry DeMarco, DRIVe Start Program Innovation & Alliance Lead, Biomedical Advanced Research & Development Authority (BARDA)
    View Bio

    12:40 End of Workshop



    Kerry DeMarco

    Kerry DeMarco

    DRIVe Start Program Innovation & Alliance Lead, Biomedical Advanced Research & Development Authority (BARDA)

    Kerry DeMarco

    DRIVe Start Program Innovation & Alliance Lead, Biomedical Advanced Research & Development Authority (BARDA)
    Kerry DeMarco

    Kerry DeMarco has been with BARDA since 2019 and currently leads the BARDA DRIVe Program & Innovation activities and runs the Beyond the Needle program. Prior to her time at BARDA, Dr. DeMarco was the Program Manager for the jointly funded BARDA/State of Texas pandemic response facility, the Texas A&M Center for Innovation in Advanced Development and Manufacturing (CIADM). Dr. DeMarco also spent over fifteen years supporting the U.S. Department of Defense Science & Technology development activities. Dr. DeMarco earned her Ph.D. in Kinesiology/Psychophysiology from the University of Maryland.


    Venue To Be Confirmed

    London, United Kingdom

    A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SMi Group. SMi Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Venue To Be Confirmed

    United Kingdom

    Venue To Be Confirmed



    speaker image






    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.


    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.


    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.


    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title


    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event


    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71

    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SMi.
    Full details of our privacy policy can be found here https://www.smi-online.co.uk/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smi-online.co.uk.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smi-online.co.uk/opt-out